A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone

Conditions:   HER2-positive Breast Cancer;   Brain Metastases Interventions:   Drug: Afatinib;   Drug: T-DM1 Sponsor:   xuexin he Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials